维普期刊资源整合服务平台（V6.5）

77篇 您的检索式：作者名="Brixius"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Endothelial progenitor cells: A new target for the prevention of cardiovascular diseases 显示文摘	Brixius K Funcke F Grat C	2006	Eur J Carelioves Prev Rehabil2006，13，5：	1
2	Effects of the Ca2+ sensitizers EMD 57033 and CGP 48506 on myocardial contractility and Ca2+ transients in human ventricular and atrial myocardium显示文摘	Brixius K Reicke S Reuter H	2002	Z Kardiol2002，91，：	1
3	Angiogenie and vascular modulation by extracellular matrix cleavage products 显示文摘	Suhr F Brixius K Bloeh W	2009	Curr Pharm Des2009，15，4：	1
4	Mesenchymal stem cells induce endothelial activation via paracine mechanisms显示文摘	Ladage D Brixius K Steingen C	2007	Endothelium2007，14，：	1
5	The preferential 133-adre- noceptor agonist BRL 37344 increases force viafM-/132-adrenocep- tors and induces endothelial nitric oxide synthase via 133-adrenocep- tors in human atrial myocardium 显示文摘	Pott C Brixius K Bundkirchen A	2003	Br J Pharmacol2003，138，3：	1
6	Benificial effects of the Ca^2+ sensitizer levosinmendan in human myocardium显示文摘	Brixius K Reicke S Schwinger RH	2002	Am J Physiol Heart Circ Physiol2002，282，1：	1
7	Benificial effects of the Ca^2+ sensitizer levosinmendan in human myocardium显示文摘	Brixius K Reicke S Schwinger RH	2002	Am J Physiol Heart Circ Physiol2002，282，1：	1
8	Effects of the Ca^2+ sensifizers EMD57033 and CGP48506 on myocardial contractility and Ca^2+ transients in human ventricular and atrial myocardium显示文摘	Brixius K Reicke S Reuter H	2002	Z Kardiol2002，91，4：	1
9	Traction prediction equations for bias ply tires 显示文摘	Brixius W W	1987	ASAE Paper1987，87，：	1
10	Effect of cy-clopiazonic acid on the force-frequency relationship in human nonfailing myocardium显示文摘	Schwinger RH Brixius K Bavendiek U	1997	J Pharmacol Exp Ther1997，283，1：	1
11	The preferential beta3-adrenoceptor agonist BRL 37344 increases force via beta1 -/beta2-adrenoceptors and induces endothelial nitric oxide synthase via beta3-adrenoceptors in human atrial myocardium显示文摘	Pott C Brixius K Bundkirchen A	2003	Br J Pharmacol2003，138，3：	1
12	Angiogenic and vascular modulation by extracellular matrix cleavage productsr显示文摘	Suhr F Brixius K Bloch W	2009	Curr Pharma Des2009，15，4：	1
13	Biomass/adsorbent electro-static interactions in expanded bed adsorption:a zeta potentialstudy显示文摘	Lin DQ Brixius PJ Kula MR	2003	Biotechnol Bioeng2003，83，2：	1
14	Blood pressure-lowering effect of nebivolol in hypertensive patients with type 2 diabetes meUitus: the YESTONO study显示文摘	Schmidt AC Graf C Brixius K	2007	Clin Drug Investig2007，27，12：	1
15	Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium显示文摘	Brixius K Bundkirchen A Bolck B	2001	Br J Pharmacol2001，133，8：	1
16	Endothelial progenitor cells: a new target for the prevention of cardiovascular diseases显示文摘	Brixius K Funcke F Graf C	2006	Eur J Cardiovasc Prey Rehabil2006，13，5：	1
17	Peroxiredoxins and sports: new insights on the antioxidative defense显示文摘	Brinkmann C Brixius K	2013	J Physiol Sci2013，63，1：	1
18	SERCA2a activity correlates with the force-frequency relationship in human myocardium显示文摘	Munch G Bolck B Brixius K	2000	Am J Physiol Heart Circ Physiol2000，278，6：	1
19	Skeletal muscle nitric oxide (NO) synthases and NO-signaling in 'diabe- sity' what about the relevance of exercise training in- terventions? 显示文摘	Eghbalzadeh K Brixius K Bloch W	2014	Nitric Oxide2014，，37：	1
20	Nitric oxide, erectile dysfunction and beta- blocker treatment (MR NOED study) : benefit of nebivolol versus metoprolol in hyperte - nsive men 显示文摘	Brixius K Middeke M Lichtenthal A	2007	Clin Exp Pharmacol Physiol2007，34，4：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示